Not Tagged
Not Tagged
['opinion']
#esmo22 clemens-martin wendtner from continues his expert opinion on the first line treatment for #cll including further trial data and use of anti-cd20 in tp53 frail patients #leusm #medicalcongress 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm